Skip to Main Content

Author Details

Paul Guilhamon
The Hospital for Sick Children
2013
25
21
PMIDPaper TitleJournal TitlePublished Year
34556523Mutations in Noncoding <i>Cis</i>-Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast Cancer.Mol Cancer Res2022
33427645Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival.Elife2021
33579912PRMT5 inhibition disrupts splicing and stemness in glioblastoma.Nat Commun2021
35122077Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity.Nat Cancer2021
32546577Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer.Cancer Discov2020
32445698Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma.Cell2020
30816925C3D: a tool to predict 3D genomic interactions between cis-regulatory elements.Bioinformatics2019
31735626Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors.Cancer Cell2019
31526762Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M Gliomas.Cancer Cell2019
31287992A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor.Cancer Cell2019
31249064High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma.Genome Res2019
31085178Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M Gliomas.Cancer Cell2019
30477433SMuRF: a novel tool to identify regulatory elements enriched for somatic point mutations.BMC Bioinformatics2018
28712938ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells.Cell Stem Cell2017
29212025Convergence of BMI1 and CHD7 on ERK Signaling in Medulloblastoma.Cell Rep2017
28886368ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells.Cell Stem Cell2017
28854171Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy.Nature2017
27960086Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.Cancer Cell2016
25175075oxBS-450K: a method for analysing hydroxymethylation using 450K BeadChips.Methods2015
25763109Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumour.Genome Med2015
24490765Using high-density DNA methylation arrays to profile copy number alterations.Genome Biol2014
25587359Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics.Genome Med2014
25171508Mucosal transcriptomics implicates under expression of BRINP3 in the pathogenesis of ulcerative colitis.Inflamm Bowel Dis2014
24518816Assessment of RainDrop BS-seq as a method for large-scale, targeted bisulfite sequencing.Epigenetics2014
23863747Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2.Nat Commun2013
  • 1 - 25 of 25

Recommended Authors

The Hong Kong University of Science and Technology
Career Start Year 2012
Number of shared co-authors 1
University of California san francisco
Career Start Year 2012
Number of shared co-authors 1
Hospital for Sick Children
Career Start Year 2011
Number of shared co-authors 13
University of North Carolina
Career Start Year 2010
Number of shared co-authors 5
Van Andel Institute
Career Start Year 2010
Number of shared co-authors 3
Gladstone Institute of Neurological Disease
Career Start Year 2010
Number of shared co-authors 0
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2010
Number of shared co-authors 39
Catholic University (KU) Leuven
Career Start Year 2010
Number of shared co-authors 6
University of California San Diego
Career Start Year 2008
Number of shared co-authors 29
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 6
St. Anna Children's Cancer Research Institute (CCRI)
Career Start Year 2007
Number of shared co-authors 2
German Cancer Research Center (DKFZ)
Career Start Year 2006
Number of shared co-authors 4
National Center for Tumor Diseases (NCT) Heidelberg
Career Start Year 2006
Number of shared co-authors 20
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 3
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year 2005
Number of shared co-authors 11
Memorial Sloan Kettering Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2004
Number of shared co-authors 6
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 9
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 4
Henry Ford Hospital
Career Start Year 2003
Number of shared co-authors 6
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 14
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 18
Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem
Career Start Year 2000
Number of shared co-authors 1
Institute for Translational Epigenetics, University of Cologne
Career Start Year 1999
Number of shared co-authors 1
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 4
Broad Institute of MIT and Harvard
Career Start Year 1994
Number of shared co-authors 8
University of California san francisco
Career Start Year 1991
Number of shared co-authors 15
Barcelona Institute of Science and Technology, Spain Universitat Pompeu Fabra
Career Start Year 1988
Number of shared co-authors 1
German Cancer Research Center
Career Start Year 1982
Number of shared co-authors 18

Collaborators

Princess Margaret Cancer Research Centre
Co-authored papers 16
The Hospital for Sick Children, University of Toronto
Co-authored papers 12
University of Toronto
Co-authored papers 8
UCL Cancer Institute, University College London
Co-authored papers 7
The Hospital for Sick Children
Co-authored papers 7
Institut Curie, PSL Research University
Co-authored papers 6
Department of Pharmaceutical Sciences, University of Toronto
Co-authored papers 5
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
University of Toronto
Co-authored papers 5
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 5
St. Michael's Hospital, University of Toronto
Co-authored papers 5
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Co-authored papers 3
Dana-Farber Cancer Institute
Co-authored papers 3
Co-authored papers 3
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
University College London, UCL Cancer Institute
Co-authored papers 3
University of Toronto, College St
Co-authored papers 3
University of Toronto
Co-authored papers 3
Co-authored papers 3
Cumming School of Medicine, University of Calgary
Co-authored papers 3
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Co-authored papers 2
University of Wollongong
Co-authored papers 2
Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children
Co-authored papers 2
Northwestern University
Co-authored papers 2
New York Presbyterian Morgan Stanley Children's Hospital
Co-authored papers 2
Illumina Cambridge Ltd.
Co-authored papers 2
Princess Margaret Cancer Research Centre
Co-authored papers 2
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Co-authored papers 2
Co-authored papers 2